Cargando…
A multi‐centre, single‐blinded randomised controlled clinical trial evaluating the effect of resorbable glass fibre matrix in the treatment of diabetic foot ulcers
Diabetic foot ulcers (DFUs) are at risk for detrimental complications even with current, standard of care (SOC) treatments. The primary objective of this randomised controlled trial was to compare a unique resorbable glass microfiber matrix (Mirragen; Advanced Wound Matrix [BBGFM]; ETS Wound Care, R...
Autores principales: | Armstrong, David G., Orgill, Dennis P., Galiano, Robert D., Glat, Paul M., DiDomenico, Lawrence A., Carter, Marissa J., Zelen, Charles M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013587/ https://www.ncbi.nlm.nih.gov/pubmed/34418302 http://dx.doi.org/10.1111/iwj.13675 |
Ejemplares similares
-
Use of a purified reconstituted bilayer matrix in the management of chronic diabetic foot ulcers improves patient outcomes vs standard of care: Results of a prospective randomised controlled multi‐centre clinical trial
por: Armstrong, David G., et al.
Publicado: (2022) -
An observational pilot study using a purified reconstituted bilayer matrix to treat non‐healing diabetic foot ulcers
por: Armstrong, David G., et al.
Publicado: (2020) -
Placental Membrane Provides Improved Healing Efficacy and Lower Cost Versus a Tissue-Engineered Human Skin in the Treatment of Diabetic Foot Ulcerations
por: Glat, Paul, et al.
Publicado: (2019) -
Improved healing of chronic diabetic foot wounds in a prospective randomised controlled multi‐centre clinical trial with a microvascular tissue allograft
por: Gould, Lisa J., et al.
Publicado: (2021) -
A multicentre, randomised controlled clinical trial evaluating the effects of a novel autologous, heterogeneous skin construct in the treatment of Wagner one diabetic foot ulcers: Interim analysis
por: Armstrong, David G., et al.
Publicado: (2021)